OptimizeRx director files initial Form 3

OptimizeRx Corp director Presti Mariyamma Varghese filed an initial Form 3, which is a statement of beneficial ownership for new insiders.

Rhea-AI Filing Summary

OptimizeRx Corp director Presti Mariyamma Varghese filed an initial Form 3, which is a statement of beneficial ownership for new insiders. The filing does not list any specific share holdings or transactions, serving mainly to register Varghese as a reporting person for the company.

Key Terms

Form 3, beneficial ownership, reporting insider

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3, which is a statement of beneficial ownership for new insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting insider regulatory

"registers Presti Mariyamma Varghese as a new reporting insider"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OptimizeRx Corp (OPRX) Form 3 filing by Presti Mariyamma Varghese mean?

The Form 3 filing registers Presti Mariyamma Varghese as a new reporting insider of OptimizeRx Corp. It is an initial statement of beneficial ownership and, in this case, does not report any specific share holdings or transactions.

Does the OptimizeRx Corp (OPRX) Form 3 show any shares owned by Presti Mariyamma Varghese?

This Form 3 lists no share holdings for Presti Mariyamma Varghese. The transaction and holding entries are all zero, so the filing functions mainly as a registration of insider status rather than a report of existing positions.

Are there any buy or sell transactions in the OptimizeRx (OPRX) Form 3 for Presti Mariyamma Varghese?

No. The Form 3 for Presti Mariyamma Varghese shows no buy, sell, acquisition, or disposition transactions. All transaction counts and share amounts are zero, indicating no trading activity is being reported in this filing.

What role does Presti Mariyamma Varghese have at OptimizeRx Corp (OPRX) according to the Form 3?

According to the Form 3, Presti Mariyamma Varghese is a director of OptimizeRx Corp. The form flags Varghese as a director and not as an officer or ten percent owner, establishing the person’s status as an insider for reporting purposes.

Why is a Form 3 important for OptimizeRx Corp (OPRX) investors?

A Form 3 identifies new insiders at OptimizeRx Corp who must publicly report their holdings and future trades. While this particular filing shows no holdings, it sets the baseline for tracking any subsequent insider activity involving this director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/22/2026 - 10:57 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Presti Mariyamma Varghese

(Last) (First) (Middle)

C/O OPTIMIZERX CORPORATION

260 CHARLES STREET, SUITE 302

(Street)

WALTHAM MASSACHUSETTS 02453

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/03/2026

3. Issuer Name and Ticker or Trading Symbol
OptimizeRx Corp [ OPRX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

No securities are beneficially owned.

	/s/ Marion Odence-Ford, by Power of Attorney	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)